Trademarkia Logo

Canada

C$
Trademark Search in Canada
AURORA CANNABIS

View On IC.GC.CA

AURORA CANNABIS
REGISTERED

on 30 Aug 2023

Last Applicant/ Owned by

1770415 Alberta Ltd.

Suite 1700, 409 Granville StreetVancouver

BRITISH COLUMBIA

CA

V6C1T2

Serial Number

1996555 filed on 19th Nov 2019

Registration Number

TMA1195138 registered on 30th Aug 2023

Registration expiry Date

30th Aug 2033

Correspondent Address

FIELD LLP

213-304 Old Canmore RoadCanmore

ALBERTA

CA

T1W0L5

AURORA CANNABIS

Trademark usage description

medicines, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antiox Read More

Classification Information

Class [005]
Medicines, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; medicines for temporary relief of seizures; medicines for the relief of nausea caused by chemotherapy; medicines for the relief of nerve pain; medicines for the treatment of muscle spasms caused by multiple sclerosis; nutraceuticals and herbs for medicinal purposes, oils, salves, concentrated pastes, tinctures, tablets and capsules, all the aforementioned products for the relief of pain and treatment in palliative care, for reducing stress and fatigue, for mood enhancement, for relief from nausea, vomiting, headaches, muscle spasms, seizures, wasting syndrome and loss of appetite in AIDS and cancer patients, for maintaining general health and well-being, for treating symptoms associated with anorexia nervosa, Crohn's disease, multiple sclerosis, amyotrophic lateral sclerosis, fibromyalgia, spinal cord injury, epilepsy, migraines, arthritides and musculoskeletal disorders, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, rheumatism, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, epilepsy, convulsant and movement disorders, cervical dystonia, Meige's syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, attention and hyperactivity disorders, Alzheimer's disease, and dementia, for the treatment of, and symptoms associated with, skin infections and irritations, namely bacterial skin infections, dermatitis, atrophie blanche, eczema, burns, rashes from skin allergies and reactions, psoriasis, pruritis and neuropathic pain, for the treatment of, and relief of symptoms associated with, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, Wilson's disease, metabolic syndrome, obesity, diabetes, diseases of the pancreas, neoplasia, and atherosclerosis, osteoarthritis, and osteoporosis, and all the aforementioned products as anti-inflammatories, anti-viral enzyme activators, analgesics, sedatives, appetite stimulants and anti-emetics, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antibacterials, antidepressants and antihypertensives; oils for the treatment of cancer; cannabidiol [CBD] oils for medical purposes; Cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for temporary relief of seizures; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nausea caused by chemotherapy; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nerve pain; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the treatment of muscle spasms caused by multiple sclerosis; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused nutraceuticals and herbs for medicinal purposes, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils, salves, concentrated pastes, tinctures, tablets and capsules, all the aforementioned products for the relief of pain and treatment in palliative care, for reducing stress and fatigue, for mood enhancement, for relief from nausea, vomiting, headaches, muscle spasms, seizures, wasting syndrome and loss of appetite in AIDS and cancer patients, for maintaining general health and well-being, for treating symptoms associated with anorexia nervosa, Crohn's disease, multiple sclerosis, amyotrophic lateral sclerosis, fibromyalgia, spinal cord injury, epilepsy, migraines, arthritides and musculoskeletal disorders, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, rheumatism, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, epilepsy, convulsant and movement disorders, cervical dystonia, Meige's syndrome, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, attention and hyperactivity disorders, Alzheimer's disease, and dementia, for the treatment of, and symptoms associated with, skin infections and irritations, namely bacterial skin infections, dermatitis, atrophie blanche, eczema, burns, rashes from skin allergies and reactions, psoriasis, pruritis and neuropathic pain, for the treatment of, and relief of symptoms associated with, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, Wilson's disease, metabolic syndrome, obesity, diabetes, diseases of the pancreas, neoplasia, and atherosclerosis, osteoarthritis, and osteoporosis, and all the aforementioned products as anti-inflammatories, anti-viral enzyme activators, analgesics, sedatives, appetite stimulants and anti-emetics, anti-nauseants, intraocular pressure reducers, anti-tumors, antioxidants, antibacterials, antidepressants and antihypertensives; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for the treatment of cancer; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for medical purposes

Classification kind code

11

Class [009]
Electronic publications, namely, newsletters, brochures, reports and guides in the field of cannabis

Classification kind code

11

Class [016]
Printed publications, namely, newsletters, brochures, reports and guides in the field of cannabis

Classification kind code

11

Class [022]
Hemp

Classification kind code

11

Class [031]
Live marijuana plants

Classification kind code

11

Class [034]
Dried cannabis; dried marijuana; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for electronic cigarettes; cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused oils for oral vaporizers for smoking; smoker's articles, namely, rolling papers, pipes, vaporizers and grinders; cannabis grinders; smoking herb grinders; marijuana grinders

Classification kind code

11

Class [035]
A product ordering service, namely a product ordering service whereby medical marijuana patients can order cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused products and medicines using a smartphone device; Retail, wholesale, and online sales of dried cannabis, live cannabis plants, dried marijuana, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused products and medicines for temporary relief of seizures, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nausea caused by chemotherapy, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the relief of nerve pain, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused medicines for the treatment of muscle spasms caused by multiple sclerosis, herbal vaporizers, oral vaporizers for smoking purposes, rolling kits for smoking, rolling papers, herbal grinders, herbal scissors, packages of smoking articles

Classification kind code

11

Class [041]
Education and counseling services, namely, providing advisory and counseling services in the field of cannabis and marijuana education; providing entertainment news and educational information in the field of cannabis and cannabis culture via a website; providing news via a website in the nature of current event reporting in the field of cannabis and cannabis culture

Classification kind code

11

Class [042]
Lab testing cannabis plants; Research services in the area of marijuana, cannabis, cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused products, derivatives of cannabis, and cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused natural health products

Classification kind code

11

Class [044]
Providing the breeding, growing, cultivation, harvesting and custom production of marijuana and cannabis; An informational service, namely an informational service whereby medical marijuana patients can obtain product information about cannabis-based, cannabis-infused, cannabinoid-based and cannabinoid-infused products and medicines using a smartphone device

Classification kind code

11

Mark Details

Serial Number

1996555

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 12
on 6th May 2022		Extension of Time
Submitted for opposition 135
on 2th Dec 2021		Amendment to Application
Submitted for opposition 12
on 14th Oct 2021		Extension of Time
Submitted for opposition 135
on 7th May 2021		Amendment to Application
Submitted for opposition 12
on 13th Apr 2021		Extension of Time
Submitted for opposition 20
on 17th Sept 2020		Examiner's First Report
Submitted for opposition 22
on 27th Feb 2020		Search Recorded
Submitted for opposition 31
on 3rd Dec 2019		Formalized
Submitted for opposition 30
on 19th Nov 2019		Filed
Submitted for opposition 1
on 19th Nov 2019		Created